This is a routine shelf update with no immediate trading catalyst. Monitor future 8-Ks or prospectus supplements for actual ATM sales, which would indicate dilution. The $3.1M baby shelf limit represents ~13% of the current $23M market cap, so any material drawdown would be notable.
Price Chart
Executive Summary
Traws Pharma filed an 8-K to update its at-the-market (ATM) offering program, supplementing its existing $50M ATM agreement with Citizens JMP Securities to allow sales of up to $3,128,399 in common stock under the company's current 'baby shelf' limitation. This is a routine administrative update to an existing equity facility, not a new capital raise, and does not provide any financial results or operational updates.
Key Facts
- Traws Pharma filed a prospectus supplement dated May 22, 2026 under its existing ATM Agreement with Citizens JMP Securities.
- The supplement authorizes sales of up to $3,128,399 in common stock, which is the company's current 'baby shelf' limitation under General Instruction I.B.6. of Form S-3.
- The original ATM Agreement was entered into on March 10, 2025 and allows aggregate sales of up to $50,000,000.
- No shares were reported as sold in this filing; the supplement merely updates the available capacity under the shelf.
- The filing includes a legal opinion from Snell & Wilmer L.L.P. regarding the validity of the shares.
Financial Impact
Up to $3,128,399 in potential equity issuance under the existing ATM facility; no actual sales reported.
Risk Factors
- Potential dilution if the company actively sells shares under the ATM facility.
- No operational or financial updates provided in this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-066345 |
| Document: tm2615554d1_ex5-1.htm | 0001104659-26-066345 |
| Document: 0001104659-26-066345-index-headers.html | 0001104659-26-066345 |
| Document: 0001104659-26-066345-index.html | 0001104659-26-066345 |
| Document: 0001104659-26-066345.txt | 0001104659-26-066345 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 2d ago | 8-K | $0.3510 | awaiting T+20 | — | $0.3372 (+3.93%) |
Oct 20, 2026 5d ago | DEFA14A | $0.3760 | awaiting T+20 | — | $0.3372 (−10.32%) |
Oct 20, 2026 5d ago | DEF 14A | $0.3760 | awaiting T+20 | — | $0.3372 (+10.32%) |
Aug 14, 2026 10w ago | Press Release | $0.5400 $0.5200 | ▲ +3.70% | ▲ +2.18% | $0.3372 (+37.56%) |
Jul 10, 2026 15w ago | 8-K | $0.6849 $0.5400 | ▲ +21.16% | ▲ +24.34% | $0.3372 (+50.77%) |
Jul 10, 2026 15w ago | 424B5 | $0.6849 $0.5400 | ▲ +21.16% | ▲ +24.34% | $0.3372 (+50.77%) |
Jul 10, 2026 15w ago | EFFECT | $0.7600 $0.5320 | ▲ +30.00% | ▲ +32.43% | $0.3372 (+55.63%) |
Jul 9, 2026 15w ago | 8-K | $0.7600 $0.5320 | ▼ −30.00% | ▼ −32.43% | $0.3372 (−55.63%) |
Jul 1, 2026 16w ago | S-3 | $0.7677 $0.4411 | ▼ −42.54% | ▼ −42.13% | $0.3372 (−56.08%) |
Jun 22, 2026 18w ago | 8-K | $0.8918 $0.6710 | ▼ −24.76% | ▼ −24.61% | $0.3372 (−62.19%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers